{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T22:56:47Z","timestamp":1772751407798,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,1,28]],"date-time":"2009-01-28T00:00:00Z","timestamp":1233100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1007\/s00774-008-0024-8","type":"journal-article","created":{"date-parts":[[2009,1,27]],"date-time":"2009-01-27T06:06:18Z","timestamp":1233036378000},"page":"168-174","source":"Crossref","is-referenced-by-count":9,"title":["Effects of risedronate or alfacalcidol on bone mineral density, bone turnover, back pain, and fractures in Japanese men with primary osteoporosis: results of a two-year strict observational study"],"prefix":"10.1007","volume":"27","author":[{"given":"Takafumi","family":"Majima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasato","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Fukao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoshi","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,1,28]]},"reference":[{"key":"24_CR1","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1007\/PL00010636","volume":"18","author":"H Orimo","year":"2000","unstructured":"Orimo H, Hashimoto T, Sakata K, Yoshimura N, Suzuki T, Hosoi T (2000) Trends in the incidence of hip fracture in Japan, 1987\u20131997: the third nationwide survey. J Bone Miner Metab 18:126\u2013131","journal-title":"J Bone Miner Metab"},{"key":"24_CR2","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1359\/jbmr.2003.18.8.1547","volume":"18","author":"S Fujiwara","year":"2003","unstructured":"Fujiwara S, Kasagi F, Masunari N, Naito K, Suzuki G, Fukunaga M (2003) Fracture prediction from bone mineral density in Japanese men and women. J Bone Miner Res 18:1547\u20131553","journal-title":"J Bone Miner Res"},{"key":"24_CR3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.3349\/ymj.2005.46.4.456","volume":"46","author":"J Iwamoto","year":"2005","unstructured":"Iwamoto J, Takeda T, Sato Y (2005) Prevention and treatment of corticosteroid-induced osteoporosis. Yonsei Med J 46:456\u2013463","journal-title":"Yonsei Med J"},{"key":"24_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00774-005-0655-y","volume":"24","author":"T Majima","year":"2006","unstructured":"Majima T, Komatsu Y, Doi K, Takagi C, Shigemoto M, Fukao A, Morimoto T, Corners J, Nakao K (2006) Clinical significance of risedronate for osteoporosis in the initial treatment of male patients with Graves\u2019 disease. J Bone Miner Metab 24:105\u2013113","journal-title":"J Bone Miner Metab"},{"key":"24_CR5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00296-005-0004-4","volume":"26","author":"JD Ringe","year":"2006","unstructured":"Ringe JD, Faber H, Farahmand P, Dorst A (2006) Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study. Rheumatol Int 26:427\u2013431","journal-title":"Rheumatol Int"},{"key":"24_CR6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00198-002-1369-9","volume":"14","author":"M Shiraki","year":"2003","unstructured":"Shiraki M, Fukunaga M, Kushida K, Kishimoto H, Taketani Y, Minaguchi H, Inoue T, Morita R, Morii H, Yamamoto K, Ohashi Y, Orimo H (2003) A double-blind dose-ranging study of risedronate in Japanese patients with osteoporosis (a study by the risedronate late phase II research group). Osteoporos Int 14:225\u2013234","journal-title":"Osteoporos Int"},{"key":"24_CR7","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/s00774-004-0494-2","volume":"22","author":"M Shiraki","year":"2004","unstructured":"Shiraki M, Fukuchi M, Kiriyama T, Okamoto S, Ueno T, Sakamoto H, Nagai T (2004) Alfacalcidol reduces accelerated bone turnover in elderly women with osteoporosis. J Bone Miner Metab 22:352\u2013359","journal-title":"J Bone Miner Metab"},{"key":"24_CR8","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF00305521","volume":"54","author":"H Orimo","year":"1994","unstructured":"Orimo H, Shiraki M, Hayashi Y, Hoshino T, Onaya T, Miyazaki S, Kurosawa H, Nakamura T, Ogawa N (1994) Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 54:370\u2013376","journal-title":"Calcif Tissue Int"},{"key":"24_CR9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1507\/endocrj.43.211","volume":"43","author":"M Shiraki","year":"1996","unstructured":"Shiraki M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H (1996) Effects of 2\u00a0years\u2019 treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43:211\u2013220","journal-title":"Endocr J"},{"key":"24_CR10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s001980050214","volume":"10","author":"M Shiraki","year":"1999","unstructured":"Shiraki M, Kushida K, Fukunaga M, Kishimoto H, Taga M, Nakamura T, Kaneda K, Minaguchi H, Inoue T, Morii H, Tomita A, Yamamoto K, Nagata Y, Nakashima M, Orimo H (1999) A double-masked multicenter comparative study between alendronate and alfacalcidol in Japanese patients with osteoporosis. The Alendronate phase III osteoporosis treatment research group. Osteoporos Int 10:183\u2013192","journal-title":"Osteoporos Int"},{"key":"24_CR11","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s001980050131","volume":"9","author":"T Tanizawa","year":"1999","unstructured":"Tanizawa T, Imura K, Ishii Y, Nishida S, Takano Y, Mashiba T, Endo N, Takahashi HE (1999) Treatment with active vitamin D metabolites and concurrent treatments in the prevention of hip fractures: a retrospective study. Osteoporos Int 9:163\u2013170","journal-title":"Osteoporos Int"},{"key":"24_CR12","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00198-003-1570-5","volume":"15","author":"F Richy","year":"2004","unstructured":"Richy F, Ethgen O, Bruyere O, Reginster JY (2004) Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 15:301\u2013310","journal-title":"Osteoporos Int"},{"key":"24_CR13","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s00774-006-0738-4","volume":"25","author":"T Fujita","year":"2007","unstructured":"Fujita T, Orimo H, Inoue T, Kaneda K, Sakurai M, Morita R, Yamamoto K, Sugioka Y, Inoue A, Takaoka K, Yamamoto I, Hoshino Y, Kawaguchi H (2007) Clinical effect of bisphosphonate and vitamin D on osteoporosis: reappraisal of a multicenter double-blind clinical trial comparing etidronate and alfacalcidol. J Bone Miner Metab 25:130\u2013137","journal-title":"J Bone Miner Metab"},{"key":"24_CR14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s007740170001","volume":"19","author":"H Orimo","year":"2001","unstructured":"Orimo H, Hayashi Y, Fukunaga M, Sone T, Fujiwara S, Shiraki M, Kushida K, Miyamoto S, Soen S, Nishimura J, Oh-Hashi Y, Hosoi T, Gorai I, Tanaka H, Igai T, Kishimoto H, Osteoporosis Diagnostic Criteria Review Committee: Japanese Society for Bone, Mineral Research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331\u2013337","journal-title":"J Bone Miner Metab"},{"key":"24_CR15","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s007740170028","volume":"19","author":"T Fujita","year":"2001","unstructured":"Fujita T, Fujii Y, Okada SF, Miyauchi A, Takagi Y (2001) Analgesic effect of etidronate on degenerative joint disease. J Bone Miner Metab 19:251\u2013256","journal-title":"J Bone Miner Metab"},{"key":"24_CR16","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00774-006-0739-3","volume":"25","author":"J Takada","year":"2007","unstructured":"Takada J, Iba K, Imoto K, Yamashita T (2007) Changes in bone resorption markers among Japanese patients with postmenopausal osteoporosis treated with alendronate and risedronate. J Bone Miner Metab 25:142\u2013146","journal-title":"J Bone Miner Metab"},{"key":"24_CR17","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1007\/BF03026321","volume":"23","author":"T Mashiba","year":"2005","unstructured":"Mashiba T, Mori S, Burr DB, Komatsubara S, Cao Y, Manabe T, Norimatsu H (2005) The effects of suppressed bone remodeling by bisphosphonates on microdamage accumulation and degree of mineralization in the cortical bone of dog rib. J Bone Miner Metab 23:S36\u2013S42","journal-title":"J Bone Miner Metab"},{"key":"24_CR18","first-page":"1022","volume":"17","author":"T Nakamura","year":"2007","unstructured":"Nakamura T, World Health Organization (2007) Absolute risk for fracture and WHO guideline. Fracture risk assessments recommended by World Health Organization and Japanese guidelines for prevention and treatment of osteoporosis 2006. Clin Calcium 17:1022\u20131028","journal-title":"Clin Calcium"},{"key":"24_CR19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00774-006-0706-z","volume":"24","author":"H Kishimoto","year":"2006","unstructured":"Kishimoto H, Fukunaga M, Kushida K, Shiraki M, Itabashi A, Nawata H, Nakamura T, Ohta H, Takaoka K, Ohashi Y, Risedronate Phase III Research Group (2006) Efficacy and tolerability of once-weekly administration of 17.5\u00a0mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen. J Bone Miner Metab 24:405\u2013413","journal-title":"J Bone Miner Metab"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-008-0024-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00774-008-0024-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-008-0024-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T06:14:22Z","timestamp":1559110462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00774-008-0024-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1,28]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["24"],"URL":"https:\/\/doi.org\/10.1007\/s00774-008-0024-8","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,28]]}}}